Next, the changes in serum levels of liver fibrosis markers (HA, PIIINP, LN, and CIV) were determined; we found that the serum levels of HA, PIIINP, LN, and CIV in the CCL4-treated group were significantly increased. This evidence concerns the gene CCL4 and Hepatic fibrosis.